| | OCTOBER 20258Procter & Gamble's latest quarterly results showed earnings per share of $1.48, which exceeded analyst projectionsProcter & Gamble Health has named Shashank Srowthy to serve as its chief financial officer beginning October 1. Srowthy will replace Lokesh Chandak, who will transition to a regional finance position within P&G Asia. With more than 14 years in various finance positions at P&G, Srowthy has operated across different roles and regions, producing successful outcomes for numerous P&G business units. His current position is director of finance for haircare operations in P&G's Asia, Middle East and Africa division.Procter & Gamble has revealed that Shashank Srowthy will take on the role of chief financial officer starting October 1. He will take over from Lokesh Chandak, who will move into a regional finance position in P&G Asia. This leadership change represents part of Procter & Gamble's continued commitment to enhancing its financial management team.Srowthy contributes more than 14 years of finance expertise at P&G, gained through various business divisions and international markets. He currently holds the position of finance director for haircare operations across P&G's Asia, Middle East, and Africa regions. His comprehensive experience and proven performance position him well to oversee Procter & Gamble's financial operations.Srowthy's appointment occurs during a time of notable developments in Procter & Gamble's financial environment. During the first quarter of 2025, Ransom Advisory Ltd made an investment of roughly $3.68 million in Procter & Gamble by purchasing 21,581 shares, establishing this as the firm's ninth largest holding. Various other hedge funds have similarly modified their PG holdings, either increasing or decreasing their positions, demonstrating continued investor attention in the company's shares.The company also declared a quarterly dividend payment of $1.0568, representing a 2.6 percent yield. Ransom Advisory Ltd acquired 21,581 shares of Procter & Gamble Company stock. The company's shares experienced a minor decline of 0.7 percent in market trading, closing at $156.72.The selection of Shashank Srowthy for the Chief Financial Officer role represents a calculated decision by Procter & Gamble to strengthen its position for ongoing financial performance and expansion. Srowthy's expertise and management capabilities will play a vital role as the company charts its path forward, especially considering the recent regulatory submissions and shareholder transactions. P&G HEALTH APPOINTS SHASHANK SROWTHY AS NEW CFOIN FOCUS
< Page 7 | Page 9 >